Netcapital Inc (NCPL)

[Positail]

From Our KingsCrowd:



Dear Early-Stage Investor,

In the throes of this raging virus pandemic, one small startup is stepping up.

KingsCrowd is teaming up with our partners at Early Investing to chat with the founder of Deal To Watch, 20/20 GeneSystems, which is gearing up to provide COVID-19 tests.

As you may remember, 20/20's main business is layering artificial intelligence over the top of blood tests to help detect cancer in its earliest stages.

They're still doing that. But due to the pressing needs of the novel coronavirus pandemic, they're moving quickly to bring a rapid COVID-19 field test to the market in the U.S.

20/20 has two goals. It wants to play a critical role in fixing the nation’s shortage of COVID-19 tests. And it wants to capture at least 5% of the coronavirus testing market.

We will sit down with Founder, President & CEO of 20/20 GeneSystems, Jonathan Cohen to hear more about their plans to do so.

Happy investing,
Chris & The KingsCrowd Team
SIGN UP FOR GENESYSTEMS 20/20 WEBINAR
KingsCrowd

50 California St., San Francisco, CA 94111

Unsubscribe - Unsubscribe Preferences